Search Result "Baricitinib"
An Estimation of Baricitinib by AQbD-driven UV Spectrophotometry-Development and Validation Process
Journal: Letters in Drug Design & Discovery
Volume: 21 Issue: 14 Year: 2024 Page: 2958-2966
Author(s): Ashwini Kumar Mishra,Hitesh Kumar Dewangan,Pravat Kumar Sahoo
Aromatic or Hetero-aromatic Directly Attached Tri and TetrasubstitutedMethanes: New Chemical Entities as Anti-Infectives
Journal: Current Medicinal Chemistry
Volume: 30 Issue: 8 Year: 2023 Page: 974-998
Author(s): Ritesh P. Thakare
Preliminary Identification of Hamamelitannin and Rosmarinic Acid as COVID-19 Inhibitors Based on Molecular Docking
Journal: Letters in Drug Design & Discovery
Volume: 18 Issue: 1 Year: 2021 Page: 67-75
Author(s): Kaushik Sarkar,Rajesh Kumar Das
First Approval of Pacritinib as a Selective Janus Associated Kinase-2 Inhibitor forthe Treatment of Patients with Myelofibrosis
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 23 Issue: 12 Year: 2023 Page: 1355-1360
Author(s): Surya K. De
Current Remedial Strategies for the Treatment of Rheumatoid Arthritisthrough the Oral Route with Janus Kinase Inhibitors
Journal: Drug Delivery Letters
Volume: 13 Issue: 1 Year: 2023 Page: 13-23
Author(s):
Potential Drugs for the Treatment of COVID-19: Synthesis, Brief History and Application
Journal: Current Drug Research Reviews
Volume: 13 Issue: 3 Year: 2021 Page: 184-202
Author(s): Ekhlass Uddin,Raisul Islam,Ashrafuzzaman,Nur Amin Bitu,Md. Saddam Hossain,ABM Nazmul Islam,Ali Asraf,Faruk Hossen,Ranjan K Mohapatra,Md. Kudrat-E-Zahan
Novel Therapeutic Approaches in Rheumatoid Arthritis: Role of Janus Kinases Inhibitors
Journal: Current Medicinal Chemistry
Volume: 26 Issue: 16 Year: 2019 Page: 2823-2843
Author(s): Felice Rivellese,Antonio Lobasso,Letizia Barbieri,Bianca Liccardo,Amato de Paulis,Francesca Wanda Rossi
The Gap in Knowledge about Tapering Targeted Therapy being used asMonotherapy in Rheumatoid Arthritis: A Systematic Review
Journal: Current Rheumatology Reviews
Volume: 20 Issue: 1 Year: 2024 Page: 46-56
Author(s): Charis F. Meng,Diviya A. Rajesh,Deanna P. Jannat-Khat
Revealing Potential Binding Affinity of FDA Approved Therapeutics Targeting Main Protease (3CLpro) in Impairing Novel Coronavirus (SARSCoV- 2) Replication that Causes COVID-19
Journal: Coronaviruses
Volume: 1 Issue: 1 Year: 2020 Page: 98-107
Author(s): D. Sivaraman,P.S. Pradeep,S. Sundar Manoharan,C. Ramachandra Bhat,K.V. Leela,V. Venugopal
Broad-Spectrum Antivirals to Combat COVID-19: the Reality and Challenges
Ebook: Coronaviruses
Volume: 2 Year: 2021
Author(s): Wafaa A. Hewedy
Doi: 10.2174/9789814998604121020003